Edoardo Mortato
8PUBLICATIONS
39CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jan 28, 2026
Long-Term Impact of Guselkumab on Systemic Inflammation Indices in Moderate-to-Severe Psoriasis.Edoardo Mortato, Lorenzo Marcelli, Agostino Panichelli
|Jan 07, 2026
Predictive Factors of Super-Responder Status to Dupilumab in Adult Atopic Dermatitis: A Real-World Monocentric Study.Edoardo Mortato, Marina Talamonti, Claudia Paganini
|Sep 22, 2025
Long-Term Real-World Effectiveness and Drug Survival of Guselkumab in Patients with Psoriasis: A 5-Year Retrospective Study.Edoardo Mortato, Marina Talamonti, Lorenzo Marcelli
|Jun 27, 2025
Could Disease Duration Influence Response to Dupilumab in Patients With Atopic Dermatitis? A Retrospective Real-Life Study.Edoardo Mortato, Marina Talamonti, Claudia Paganini
|Jun 03, 2025
Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab.Angela Fico, Edoardo Mortato, Claudia Paganini
|Apr 16, 2025
Effects of Guselkumab on the FIB-4 Index in Psoriasis Patients (EGIPT): A Three-Year Study.Edoardo Mortato, Lorenzo Marcelli, Lorenzo Tofani
Pageof 2
Frequent Collaborators
5 joint publications
Marco Galluzzo
5 joint publications
Marina Talamonti
3 joint publications
Claudia Paganini
2 joint publications
Nicoletta Bernardini
2 joint publications
Cosimo Di Raimondo
2 joint publications
Luca Bianchi
1 joint publications
Clara De Simone
1 joint publications
Fabio Artosi
1 joint publications
Martina Burlando
1 joint publications
Andrea Carugno
